KAPRUVIA sol inj 0.05 mg/ml 3 flac 1 ml
7680686530010
CH-68653
V03AX04
05.99.0.
Reimbursement limitations:
KAPRUVIA.01
Avant le début du traitement, une garantie de prise en charge des coûts par l’assurance …
1 / 3
google
Details
- Product number
- 6865301
- CPT
- -
- Packaging group
- 3 x 1 ml
- Unit
- Durchstechflasche(n)
- Composition
- difelikefalinum 50 µg ut difelikefalini acetas, acidum aceticum, natrii acetas trihydricus, natrii chloridum, aqua ad iniectabile, q.s. ad solutionem pro 1 ml corresp. natrium 3.3 mg.
Articles (1)
Kapruvia 50 µg/ml, Injektionslösung
Injektionslösung
3 x 1 ml
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.3 MG | Substance | HBESI |
Authorization holder
Vifor Fresenius Medical Care
9014 St. Gallen
Authorization information
- Swissmedic authorization number
- 68653
- Drug name
- Kapruvia, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- V03AX04
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 16/08/2022
- Authorization expiration date
- 15/08/2027
- IT number
- 05.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- KAPRUVIA sol inj 0.05 mg/ml 3 flac 1 ml
- Description (DE)
- KAPRUVIA Inj Lös 0.05 mg/ml 3 Durchstf 1 ml
- Market launch
- 16/08/2022
- Narcotic (BTM)
- No